Table 5. Hazard ratio (95% confidence intervals) for a 1 standard deviation (6 cm) increase in height in relation to selected cancer outcomes – overall and with 3 yr left censoring.
| Sex | Overall (N=506,648) | With 3 yr. left censoring (N=482,438) | |||
|---|---|---|---|---|---|
| No. of deaths | HR (95% CI) | No. of deaths | HR (95% CI) | ||
| Pancreas | M F |
194 100 |
1.08 (0.94, 1.24) 0.99 (0.82, 1.21) |
133 82 |
1.19 (0.95, 1.50) 1.01 (0.73, 1.40) |
| Leukaemia | M F |
130 59 |
1.03 (0.87, 1.21) 1.01 (0.79, 1.31) |
85 48 |
0.94 (0.72, 1.22) 1.11 (0.75, 1.64) |
| Bladder | M F |
97 22 |
1.31 (1.09, 1.58) 1.43 (0.97, 2.13) |
63 * |
1.55 (1.09, 2.19) |
| Brain | M F |
141 57 |
1.06 (0.90, 1.25) 0.96 (0.74, 1.25) |
103 45 |
0.93 (0.72, 1.20) 0.72 (0.46, 1.12) |
| Kidney | M F |
67 23 |
1.04 (0.83, 1.31) 1.21 (0.81, 1.83) |
44 20 |
1.04 (0.83, 1.31) 1.45 (0.80, 2.62) |
| Ovary/uterus | M F |
** 195 |
1.08 (0.94, 1.25) |
* 59 |
1.29 (1.00, 1.65) |
| Melonoma | M F |
63 25 |
1.44 (1.15, 1.79) 1.04 (0.71, 1.52) |
43* | 1.23 (0.89, 1.68) |
| Upper Aero digestive Tract | M F |
329 79 |
0.93 (0.84, 1.04) 1.16 (0.92, 1.45) |
212 57 |
0.95 (0.78, 1.15) 1.26 (0.74, 2.15) |
| Other | M F |
546 228 |
1.02 (0.94, 1.11) 1.11 (0.96, 1.27) |
424 168 |
1.15 (0.96, 1.37) 1.44 (1.13, 1.85) |
All hazard ratios are age, study, and year of birth adjusted
*
too few events to run analyses
**
not applicable